MedPath

621 Real World Study

Not Applicable
Recruiting
Conditions
Senile Cataract
Registration Number
NCT05646004
Lead Sponsor
Carl Zeiss Meditec AG
Brief Summary

This study is evaluating the clinical safety and effectiveness of 621, after cataract surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
105
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Corrected Distance Visual Acuity (CDVA)6 months

measurement of CDVA after IOL implantation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hainan Boao Lecheng Aier Eye Hospital

🇨🇳

Qionghai, Hainan, China

Hainan Boao Lecheng Aier Eye Hospital
🇨🇳Qionghai, Hainan, China
Aier Eye
Contact
13118913565

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.